B-Path is an EU-funded initiative focused on transforming the way we diagnose respiratory infections—such as SARS-CoV-2, influenza, and tuberculosis—by using exhaled breath aerosols (XBA) as a novel, non-invasive diagnostic sample. Our goal is to develop portable, accessible, and reliable tools that bring accurate diagnostics closer to patients, especially in resource-limited settings.Why Follow @bpath.bsky.social?🧬 Innovation in Respiratory Diagnostics
Get the latest updates on our research, technological advances, and project milestones.🌐 Global Collaboration & Impact
See how B-Path is building partnerships and driving change in diagnostics worldwide.📖 Stories from the Field
Discover how our work is making a difference—from lab discoveries to real-world impact.👉 Follow us now at: @b-patheu.bsky.socialLet’s breathe new life into diagnostics—together.
